Holen Sie sich die Stockscreener-App
12.82
4.19%
-0.56
Schlusskurs vom Vortag:
$13.38
Offen:
$13.38
24-Stunden-Volumen:
1.50M
Relative Volume:
1.04
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.61%
1M Leistung:
-14.08%
6M Leistung:
-49.37%
1J Leistung:
-52.81%
1-Tages-Spanne:
$12.67
$13.38
1-Wochen-Bereich:
$12.67
$13.54
52-Wochen-Spanne:
$9.60
$28.77
Defiance Daily Target 2 X Long Lly Etf Stock (LLYX) Company Profile
Firmenname
Defiance Daily Target 2 X Long Lly Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie LLYX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LLYX
Defiance Daily Target 2 X Long Lly Etf
|
12.82 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
319.55 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
647.24 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
650.47 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
255.52 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
576.06 | 124.43B | 0 | 0 | 0 | 0.00 |
Defiance Daily Target 2 X Long Lly Etf Aktie (LLYX) Neueste Nachrichten
US launches from 28th August to 4th September, 2025 - ETF Express
Defiance Launches 2X Short ETF on Eli Lilly for Retail Investors - AInvest
Defiance’s LLYZ ETF: A Leveraged Bet Against Eli Lilly Amid Biopharma Sector Turbulence - AInvest
Defiance Launches LLYZ: The First 2X Short ETF for Eli Lilly - GlobeNewswire
Defiance Launches LLYZ: A New 2X Short ETF for Eli Lilly Investors - AInvest
Weekly ETF Industry News Recap | August 25August 29, 2025 - Trackinsight
Largest Borrow Rate Increases Among Liquid Stocks - AInvest
U.S. Stock ETF Tracking | Eli Lilly and Co's weight loss drug is expected to submit for FDA approval within the year, resulting in a more than 11% increase in the 2x long LLY ETF; international oil prices have fallen to nearly $60 per barrel, leading to o - 富途牛牛
Novo Nordisk Plunges 2.6% Amid Legal Storm and Rival Drug Data – What’s Next for NVO? - AInvest
Eli Lilly's LLY Surges 4.38% on Groundbreaking Obesity Drug Data – What's Next for the Pharma Giant? - AInvest
Best-Performing Leveraged ETFs of Last Week - Yahoo Finance
Big Tech Woes Power Surge in Inverse Single-Stock ETFs - Yahoo Finance
Novo Nordisk Surges 2.46% Amid Leadership Shift and Sector Volatility – What’s Fueling the Rally? - AInvest
Eli Lilly Surges 3.36% Amid UK Price Hike and AI-Driven Obesity Deal: What’s Fueling the Rally? - AInvest
Eli Lilly Surges 3% on Insider Buying and Regulatory Drama – What’s Next? - AInvest
Eli Lilly Soars on Insider Buying Amid Regulatory Storm: A 3% Rally Amid Legal and Trial Turmoil - AInvest
Eli Lilly Surges 2.48% Amid Regulatory Turmoil and Sector Volatility – What’s Fueling the Rally? - AInvest
Novo Nordisk Surges 4.7% Amid Obesity Drug Rivalry: Is This the New Benchmark? - AInvest
US ETF Tracker | Trump announces nomination of Stephen Moore for Federal Reserve governor, double-leveraged small gold miners index ETF rises nearly 3%, Eli Lilly and Co's new drug underperforms expectations, double-leveraged LLY ETF falls over 28 - 富途牛牛
Sarepta Soars 8.55% on Earnings & FDA Greenlight: Can This Biotech Rebound Sustain Momentum? - AInvest
NVO's 6.37% Surge: A Bullish Rebound Amid Earnings Volatility and Sector Shifts - AInvest
Defiance Launches QPUX: 2X Leveraged ETF on Pure Quantum Companies - Yahoo Finance
Eli Lilly's Stock Plummets 13.78%: A Volatile Day in the Pharma Giant's Journey - AInvest
Eli Lilly Plummets 3% as Sector Turmoil and Rival Struggles Ignite Selling Frenzy - AInvest
U.S. Market Outlook | Equity Index Futures Rise, Super Micro Computer (SMCI.US) Falls Post-Earnings, Trump to Make Statement After Market Close - 富途牛牛
Leveraged Bearish Strategy ETF Surges 19%, Signals Dour Outlook for MSTR and Bitcoin - Yahoo Finance
Novo Nordisk Plummets 3.87% Amid Earnings Woes and Sector Headwinds – What’s Next for the GLP-1 Giant? - AInvest
Novo Nordisk Plunges 3.45%: Is This the Bottom or a Deeper Downtrend? - AInvest
Novo Nordisk Plunges 4.56%—Is This a Golden Entry Point or a Deepening Abyss? - AInvest
Novo Nordisk Plunges 5.7%—What’s Fueling the Crisis of Confidence? - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - Yahoo Finance
Novo Nordisk Plunges 21.19%—What’s Behind the Sudden Collapse? - AInvest
Form 485BPOS Tidal Trust II - StreetInsider
Defiance Launches JPX: The First 2X Leveraged ETF on JPM (JP Morgan) - FinancialContent
Novo Nordisk Skyrockets 4.78%—What’s Fueling This High-Stakes Surge? - AInvest
Novo Nordisk Skyrockets 2.71% Intraday—Is This the Dawn of a New Obesity Drug Era? - AInvest
U.S. ETF Tracking | Online Car-hailing giant Uber Technologies will invest $300 million in electric car manufacturer Lucid, leading to a 73% surge in the 2x leveraged LCID ETF; the 2x leveraged QBTS ETF rose by over 27%. - 富途牛牛
Wall Street's top and bottom 20 performing ETFs YTD as H1 concludes - Seeking Alpha
Defiance Launches First Mover Single-Stock Leverage ETFs: IONZ (2X Short IONQ), OKLL (2X Long OKLO), and SOUX (2X Long SOUN) - Yahoo Finance
Weekly ETF Industry Recap: U.S., Europe, and Canada Highlights – June 2-6, 2025 - Trackinsight
GameStop Covered Call ETF Debuts Amid Meme Stock Resurgence - Yahoo Finance
5 ETF Areas That Thrived Amid the Trump-Musk Feud Yesterday - Yahoo Finance
Defiance Launches CVNX: The First 2X Long ETF for Carvana Co. - Yahoo Finance
Top-Performing Leveraged ETFs of Last Week - Nasdaq
ETF Spotlight: HIMZ on the Rise After Wegovy Hookup - ETF.com
5 Single-Stock ETFs That Doubled in a Month - Nasdaq
Tidal to implement 1-for-20 reverse stock split for 2x short MSTR fund (SMST:NASDAQ) - Seeking Alpha
ETF (Exchange Traded Fund): Rankings and news - marketscreener.com
Best Stocks Under $50 Right Now - Benzinga
Finanzdaten der Defiance Daily Target 2 X Long Lly Etf-Aktie (LLYX)
Es liegen keine Finanzdaten für Defiance Daily Target 2 X Long Lly Etf (LLYX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
0.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):